Global
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
119.93%
|
Dec. 31, 2023 | USD 1.11 | -3.12% |
|
Poland |
|
2 |
103.77%
|
Dec. 31, 2023 | USD 5.91 | -0.34% |
|
Israel |
|
3 |
61.98%
|
Sept. 30, 2024 | USD 33.62 | -2.24% |
|
United States |
|
4 |
60.21%
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
|
5 |
49.97%
|
Dec. 31, 2023 | USD 17.87 | -4.83% |
|
Switzerland |
|
6 |
48.65%
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
7 |
41.79%
|
Sept. 30, 2024 | USD 8.54 | -1.84% |
|
United States |
|
8 |
39.45%
|
Sept. 30, 2024 | USD 71.38 | -1.48% |
|
United States |
|
9 |
38.70%
|
Sept. 30, 2024 | USD 5.78 | -3.34% |
|
United States |
|
10 |
36.32%
|
Dec. 31, 2023 | USD 10.11 | NA |
|
South Korea |
|
11 |
35.57%
|
Dec. 31, 2023 | USD 30.85 | -1.29% |
|
Sweden |
|
12 |
30.98%
|
Sept. 30, 2024 | USD 37.20 | -1.59% |
|
United States |
|
13 |
29.19%
|
Dec. 31, 2023 | USD 7.29 | NA |
|
China |
|
14 |
28.34%
|
Dec. 31, 2023 | USD 4.35 | -2.22% |
|
France |
|
15 |
26.61%
|
Dec. 31, 2023 | USD 81.94 | -2.80% |
|
Denmark |
|
16 |
25.90%
|
Sept. 30, 2024 | USD 469.04 | 11.13% |
|
United States |
|
17 |
25.30%
|
June 30, 2024 | USD 59.97 | -3.38% |
|
India |
|
18 |
23.69%
|
Dec. 31, 2023 | USD 9.06 | -3.10% |
|
Canada |
|
19 |
23.13%
|
March 31, 2024 | USD 298.59 | -1.07% |
|
India |
|
20 |
22.93%
|
Dec. 31, 2023 | USD 17.21 | -0.35% |
|
Israel |
|
21 |
22.89%
|
Sept. 30, 2024 | USD 89.54 | -3.21% |
|
United States |
|
22 |
22.61%
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
23 |
22.41%
|
Sept. 30, 2024 | USD 51.90 | -3.89% |
|
Poland |
|
24 |
21.99%
|
Sept. 30, 2024 | USD 22.62 | 0.27% |
|
United States |
|
25 |
21.29%
|
Dec. 31, 2023 | USD 66.91 | -1.44% |
|
Spain |
|
26 |
21.29%
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
27 |
20.49%
|
Sept. 30, 2024 | USD 56.28 | -0.64% |
|
United States |
|
28 |
20.36%
|
Sept. 30, 2024 | USD 66.55 | -0.55% |
|
United States |
|
29 |
20.14%
|
June 30, 2024 | USD 72.96 | -6.14% |
|
Denmark |
|
30 |
20.10%
|
March 31, 2024 | USD 13.35 | -1.36% |
|
India |
|
31 |
19.92%
|
Dec. 31, 2023 | USD 9.72 | -0.43% |
|
Japan |
|
32 |
19.83%
|
Sept. 30, 2024 | USD 0.82 | -2.86% |
|
South Africa |
|
33 |
19.82%
|
Dec. 31, 2023 | USD 2.23 | -2.59% |
|
Poland |
|
34 |
19.61%
|
Sept. 30, 2024 | USD 343.38 | -1.65% |
|
United States |
|
35 |
19.36%
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
36 |
19.33%
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
37 |
18.83%
|
Sept. 30, 2024 | USD 16.47 | 1.98% |
|
United States |
|
38 |
18.78%
|
Sept. 30, 2024 | USD 50.46 | -2.89% |
|
United States |
|
39 |
18.61%
|
Dec. 31, 2023 | USD 0.21 | -0.01% |
|
Indonesia |
|
40 |
18.44%
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
|
41 |
18.12%
|
March 31, 2024 | USD 24.60 | -1.01% |
|
India |
|
42 |
17.14%
|
March 31, 2024 | USD 5.30 | 1.07% |
|
India |
|
43 |
17.09%
|
March 31, 2024 | USD 27.76 | -1.36% |
|
India |
|
44 |
17.01%
|
Sept. 30, 2024 | USD 171.94 | 0.61% |
|
United States |
|
45 |
16.84%
|
Dec. 31, 2023 | USD 43.21 | -0.41% |
|
Japan |
|
46 |
16.65%
|
Dec. 31, 2023 | USD 31.53 | -1.19% |
|
Ireland |
|
47 |
16.59%
|
March 31, 2024 | USD 22.77 | -0.11% |
|
India |
|
48 |
16.37%
|
March 31, 2024 | USD 163.13 | 0.16% |
|
India |
|
49 |
16.30%
|
Sept. 30, 2024 | USD 59.10 | NA |
|
United States |
|
50 |
16.29%
|
March 31, 2024 | USD 2.39 | -4.30% |
|
India |
The Biotechnology company in the world with the highest Return on Assets (ROA) is Pharmena S.A. (Warsaw Stock Exchange: PHR.WA) at 119.93%.
The Biotechnology company in the world with the lowest Return on Assets (ROA) is Sequana Medical NV (Brussels Stock Exchange: SEQUA.BR) at -322.38%.
The top 10 Biotechnology companies in the world by Return on Assets (ROA) are Pharmena S.A., RedHill Biopharma Ltd., Agios Pharmaceuticals, Inc., Roivant Sciences Ltd., Santhera Pharmaceuticals Holding AG, Oncimmune Holdings plc, MiMedx Group, Inc., Edwards Lifesciences Corporation, SIGA Technologies, Inc. and Osang Healthcare Co.,Ltd.
The bottom 10 Biotechnology companies in the world by Return on Assets (ROA) are Sequana Medical NV, TriSalus Life Sciences, Inc., Calidi Biotherapeutics, Inc., Evaxion Biotech A/S, Longeveron Inc., Galectin Therapeutics Inc., GENinCode plc, 22nd Century Group, Inc., Biohaven Pharmaceutical Holding Company Ltd. and Inventiva S.A..